Radiofrequency and cryoballoon ablation improve cognitive function in patients with atrial fibrillation
- PMID: 34397930
- PMCID: PMC8360464
- DOI: 10.1097/MD.0000000000026914
Radiofrequency and cryoballoon ablation improve cognitive function in patients with atrial fibrillation
Abstract
Atrial fibrillation is considered to be the most common arrhythmia in the clinic, and it gradually increases with age. In recent years, there has been increasing evidence that atrial fibrillation may exacerbate the progression of cognitive dysfunction. The current guidelines recommend ablation for drug-refractory atrial fibrillation.We aimed to prospectively analyze changes in cognitive function in patients with atrial fibrillation following treatment using different ablation methods.A total of 139 patients, with non-valvular atrial fibrillation, were included in the study. The patients were divided into the drug therapy (n = 41) and catheter ablation (n = 98) groups, with the catheter ablation group further subdivided into radiofrequency ablation (n = 68) and cryoballoon (CY) ablation (n = 30). We evaluated cognitive function at baseline, 3- and 12-months follow-up using the Telephone Interview for Cognitive Status-modified (TICS-m) test, then analyzed differences in cognitive function between the drug therapy and catheter ablation groups, to reveal the effect of the different ablation methods.We observed a significantly higher TICS-m score (39.56 ± 3.198) in the catheter ablation group at 12-month follow-up (P < .001), than the drug treatment group was. Additionally, we found no statistically significant differences in TICS-m scores between the radiofrequency ablation and CY groups at 3- and 12-month postoperatively (P > .05), although the two subgroups showed statistically significant cognitive function (P < .001).Overall, these findings indicated that radiofrequency and CY ablation improve cognitive function in patients with atrial fibrillation.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- Guo Y, Tian Y, Wang H, et al. . Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest 2015;147:109–19. - PubMed
-
- Chinta V, Askandar S, Nanda A, et al. . Atrial fibrillation and deterioration in cognitive function. Curr Probl Cardiol 2018;44:100386. - PubMed
-
- Madhavan M, Graff-Radford J, Piccini JP, et al. . Cognitive dysfunction in atrial fibrillation. Nat Rev Cardiol 2018;15:744–56. - PubMed
-
- Chopard R, Piazza G, Gale SA, et al. . Dementia and atrial fibrillation: pathophysiological mechanisms and therapeutic implications. Am J Med 2018;131:1408–17. - PubMed
-
- Mahajan R, Brooks AG, Sullivan T, et al. . Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart 2012;98:1120–6. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical